- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 49.36M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 57.78M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 3.16M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$24.08M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$18.76M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $256.21M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $247.72M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $55.09M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $88.44M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $296.46M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $332.52M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | −$83.51M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | −$46.8M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $22.29M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $16.54M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $22.97M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $17.26M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $318.52M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $348.82M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $319.43M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $349.78M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.57 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$12.10 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.57 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$12.10 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $7.39M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $3.36M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $36.05M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $20.02M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$40.37M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$38.17M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$43.45M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$23.38M |